Search

everythinglearnresearchcommunity

for

Search:↓

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Fungal skin infections significantly lower patients' quality of life.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

MPZL3 is crucial for seborrheic dermatitis development.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

Psoriasis patients are more likely to experience maladaptive daydreaming.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

The improved algorithm enhances low-dose CT image quality significantly better than other methods.

Dermoscopy helps diagnose folliculotropic mycosis fungoides by identifying specific skin patterns.

Increasing TSPO in the brain may help improve memory problems.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.

Hair root analysis can effectively detect somatic mosaicism in double cortex syndrome.

Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Some people have a genetic variation that makes them less effective at breaking down drugs.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

The new minoxidil emulgel with marine-based polymers shows effective controlled drug release for hair growth treatment.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

The new microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

The new minoxidil formulation could better promote hair growth for treating androgenic alopecia.